LMOS

Trust and status

What is true today, and what is not yet.

LMOS is in development. This page says where each commitment stands, in words we are prepared to be held to.

TopicWhere it standsStatus
Patient dataLMOS is designed to hold none, in either deployment. The rule is enforced and tested as the system is built.Design rule
Clinical roleLMOS enforces the lab's own SOPs and paperwork. It makes no clinical decisions.Design rule
IsolationThe on-premise tier is designed to run isolated from the public internet, with controlled, authenticated integration points. The cloud tier separates each laboratory as its own tenant.Design rule
SOC 2 Type 2Examination in progress. No report has been issued yet.In progress
21 CFR Part 11Designed to support its requirements: attributable signatures, an append-only audit trail. A design target; no validation has been run.Design target
ValidationInstallation, operational and performance qualification will be executed with each customer's quality team.Planned
HIPAA, ISO 27001Planned for the cloud tier.Planned
Public regulations21 CFR 606, 610, 640, 600, 607 and Part 11; 42 CFR 493 and 482; FDA guidance on blood establishment computer software validation; OSHA bloodborne pathogens.In design
Licensed standardsAABB, CAP, The Joint Commission, ISO 15189, COLA and CLSI come from the customer's own license. LMOS does not bundle them or copy them between laboratories.Design rule
CustomersBuilt with input from an informal network of laboratory directors. The first pilot cohort is forming.Forming

How we word claims

We say designed to when something is a design intent, planned when it has not started, and in progress when work is under way. We do not describe anything as certified, approved or validated until the document that proves it exists. If you spot a statement on this site that runs ahead of that standard, tell us at hello@lmos.bio.

Pilot program

Ask us the hard questions.

Your security and quality teams will have them. We would rather answer them early.

Contact us